Sponsor Pipeline

Christian Schulze Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT07038356
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on…		 Trial sites expanded: 9 -> 12 locations
2026-08-12 NCT07038356
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on…		 date change Primary completion pushed: 2026-04-30 -> 2027-04-30
2026-08-12 NCT07038356
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on…		 date change Completion pushed: 2026-06-30 -> 2027-06-30
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07038356 Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on… Acute Decompensated Heart Failure (ADHF) Recruiting
Disease Areas
Heart Failure (1)
Get alerts when Christian Schulze's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free